Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8165016 | 0.83 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL14724288 | 0.81 | TSHR (0.40) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL169726 | 0.80 | ALDH1A1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL1489551 | 0.80 | LMNA (0.32) | ALDH1A1LMNA | |
| SCHEMBL1489552 | 0.80 | LMNA (0.32) | ALDH1A1LMNA | |
| SCHEMBL7591554 | 0.77 | ALDH1A1 (0.38) | TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL931342 | 0.76 | TSHR (0.35) | TSHRALDH1A1CYP3A4SMN1; SMN2LMNA | |
| SCHEMBL1489359 | 0.76 | TSHR (0.33) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL27331593 | 0.76 | TSHR (0.36) | TSHR | |
| SCHEMBL19339595 | 0.76 | RAB9A (0.30) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| EP-1655279-B1 | Process for the preparation of vinyl acetate | CELANESE SALES GERMANY GMBH (DE) | 2017-02-22 | — | — | EP | disclosed |
| CN-103237784-B | For the production of the method for vinyl acetate composition with low impurity content | CELANESE INTERNATIONAL CORP. (US) | 2015-11-25 | — | — | CN | disclosed |
| US-7135591-B2 | Adhesive based on biodegradable acrylates | LIJMTECHNIEK B.V. (NL) | 2006-11-14 | — | — | US | disclosed |
| EP-1655279-A1 | Process for the preparation of vinyl acetate | Celanese Chemicals Europe GmbH (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-20050085608-A1 | Adhesive based on biodegradable acrylates | LIJMTECHNIEK B.V. (NL) | 2005-04-21 | — | — | US | disclosed |
| EP-0898494-B1 | A TWO STEP GOLD ADDITION METHOD FOR PREPARING A VINYL ACETATE CATALYST | HOECHST CELANESE CORP (US) | 2000-06-14 | — | — | EP | disclosed |
| EP-0891224-B1 | A METHOD OF PREPARING A VINYL ACETATE CATALYST EMPLOYING AN ALKALI METAL BORATE | HOECHST CELANESE CORP (US) | 1999-11-24 | — | — | EP | disclosed |
| EP-0898494-A1 | A TWO STEP GOLD ADDITION METHOD FOR PREPARING A VINYL ACETATE CATALYST | Hoechst Celanese Corporation (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0891224-A1 | A METHOD OF PREPARING A VINYL ACETATE CATALYST EMPLOYING AN ALKALI METAL BORATE | Hoechst Celanese Corporation (US) | 1999-01-20 | — | — | EP | disclosed |
| US-5691267-A | Two step gold addition method for preparing a vinyl acetate catalyst | HOECHST CELANESE CORPORATION (US) | 1997-11-25 | — | — | US | disclosed |
| WO-1997038790-A1 | A TWO STEP GOLD ADDITION METHOD FOR PREPARING A VINYL ACETATE CATALYST | HOECHST CELANESE CORPORATION (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1997036678-A1 | A METHOD OF PREPARING A VINYL ACETATE CATALYST EMPLOYING AN ALKALI METAL BORATE | HOECHST CELANESE CORPORATION (US) | 1997-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085608-A1 | Adhesive based on biodegradable acrylates | CAD, PTK2, ICAM1 | TSHR 4377/4885ALDH1A1 187/4885CYP3A4 3061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.